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Resumen 
La microfluídica es un área de la microtecnología basada en chips de PDMS 
que está siendo utilizada cada vez más en multitud de aplicaciones. Una de 
estas aplicaciones es la investigación biomédica. La microfluídica o “Lab on a 
Chip” se ha convertido en una manera de realizar experimentos biomédicos y 
diagnósticos de una manera barata, rápida y eficaz. Cuando se realizan 
estudios sobre la extravasación leucocitaria utilizando chips microfluídicos, 
podemos observar la inconsistencia en la trayectoria de rodadura de los 
leucocitos debido a un flujo laminar. En este trabajo de fin de grado 
presentamos un método para centrar la interfaz de células en el centro de canal 
microfluídico. Cuando las células circulan por los sistemas microfluídicos, las 
células tienden a circular de manera aleatoria por los canales. Por tanto, con el 
sistema propuesto en este trabajo, dichas células serán redirigidas a la porción 
central del canal con el fin de recrear el fenómeno de rodadura presente en 
nuestro sistema circulatorio y así obtener información más detallada. Los 
resultados de este trabajo muestran la utilidad y la versatilidad de este 
dispositivo para experimentos relacionados.     
Palabras clave: Microfluídica, Lab on a Chip, Point of Care, Extravasación 
Leucocitaria, Litografía blanda, Inmunología, Modelado Multifísico, Método de 
elementos finitos. 
  
 
 
Abstract  
Microfluidics is an area of technology based on PDMS chips that is being 
increasingly used for many applications. One of said applications is biomedical 
research. Microfluidics or Lab on a chip poses as a great way of cutting costs, 
time, space and overall improving efficiency in medical diagnosis and 
biomedical experiments. When studying the rolling cell adhesion behaviour of 
leukocytes on microfluidic devices, we can observe the inconsistency in the 
manner cells roll due to laminar flow. In this final year dissertation we present a 
method to focus the flow of leukocytes on a rectangular microfluidic channel for 
rolling cell adhesion assays. When flowing in microfluidic channels, cells tend to 
circulate in a random manner, therefore with the system proposed, said cells 
will circulate in the central area of the channel, in order to optimally recreate the 
rolling cell adhesion phenomenon present in our circulatory system and achieve 
precise information regarding this cellular behaviour. The results of this work 
show the viability of the system and the versatility it may have with other related 
experiments.     
Keywords: Microfluidics, Lab on a Chip, Point of Care, Rolling Cell Adhesion, 
Hydrodynamic flow focusing, Soft Lithography, Immunology, Multiphysics 
Modelling, Finite Element Method.  
  
 
 
Acknowledgements  
To my parents for making the trip to Japan, where this dissertation was 
developed, possible, for never losing faith in me and for always supporting my 
decisions. 
To my sister, for encouraging me to try my hardest in every step along the way. 
To the Professors José Antonio Andrades Gómez and Joaquín Ortega 
Casanova, for getting involved in this project and for their help developing the 
content of this dissertation. 
To Masahiro Motosuke, for allowing me to work at his lab, where I learnt so 
much. 
To Sayaka Nomura and Takuya Ichikawa, for being great colleagues and 
helping me with this research.  
  
 
 
 
 
Contents  
Chapter 1: Introduction ..................................................................................... 13 
1.1 Background and Motivation ........................................................................ 13 
1.2 Objectives ................................................................................................... 14 
1.3 Content Outline .......................................................................................... 15 
 
Chapter 2: The Immune System ....................................................................... 17 
2.1 The Immune System .................................................................................. 17 
2.1.1 Haematopoiesis ................................................................................... 18 
2.1.2 Immune System Organs ...................................................................... 20 
2.2 Leukocyte Activation and Migration ............................................................ 22 
2.2.1 Cell Adhesion Molecules ...................................................................... 22 
2.2.2 Leukocyte Extravasation ...................................................................... 24 
2.2.3 Leukocyte Adhesion Deficiency ........................................................... 25 
 
Chapter 3: Microfluidics .................................................................................... 27 
3.1 What is Microfluidics? ................................................................................. 27 
3.2 Properties of Fluidics .................................................................................. 28 
3.3 Shear Stress ............................................................................................... 29 
3.4 Types of Fluids ........................................................................................... 29 
3.5 Types of Flows ........................................................................................... 30 
3.5.1 Laminar flow ........................................................................................ 30 
3.6 Hydrodynamic Focusing ............................................................................. 32 
3.6.1 Conservation of Energy ....................................................................... 33 
3.7 Lab on a Chip ............................................................................................. 34 
3.7.1 Organ on a chip ................................................................................... 35 
 
 
Chapter 4: Simulations ..................................................................................... 37 
4.1 Introduction ................................................................................................. 37 
4.2 Simulations ................................................................................................. 37 
4.2.1 Fluid Flow Simulation ........................................................................... 37 
4.2.2 Sheath Flow Simulation ....................................................................... 40 
4.2.3 Particle tracing sheath flow Simulation ................................................ 44 
4.2.3.1 Particle parameters ....................................................................... 46 
4.3 Discussion .................................................................................................. 46 
 
Chapter 5: Materials & Method ......................................................................... 47 
5.1 Rolling Cell Adhesion Microfluidic Device................................................... 47 
5.2 Channel Geometry ..................................................................................... 47 
5.3 Microfabrication Technology ....................................................................... 48 
5.3.1 Electron Beam Lithography .................................................................. 48 
5.3.1.1 Photomask Creation ...................................................................... 48 
5.3.2 Photolithography .................................................................................. 52 
5.3.2.1 Silicon patterning procedure .......................................................... 53 
5.3.3 PDMS Channel .................................................................................... 56 
5.4 E-Selectin substrate preparation ................................................................ 57 
5.5 Leukocyte culture ....................................................................................... 58 
 
Chapter 6: Experimental Results ...................................................................... 61 
6.1 Sheath Flow Experiment ............................................................................ 61 
6.1.1 Experimental Setup.............................................................................. 61 
6.1.2 Results ................................................................................................. 62 
6.1.3 Discussion ........................................................................................... 64 
6.2 Rolling Cell Experiment .............................................................................. 64 
 
 
6.2.1 Experimental Setup.............................................................................. 65 
6.2.2 Results ................................................................................................. 65 
6.2.3 Discussion ........................................................................................... 66 
6.3 Rolling Cell Sheath Flow Experiment ......................................................... 67 
6.3.1 Experimental Setup.............................................................................. 67 
6.3.2 Results ................................................................................................. 67 
6.3.3 Discussion ........................................................................................... 68 
6.4 Pulsation Experiment ................................................................................. 69 
6.4.1 Experimental Setup.............................................................................. 69 
6.4.2 Results ................................................................................................. 70 
6.4.3 Discussion ........................................................................................... 70 
 
Chapter 7: Conclusion ...................................................................................... 71 
7.1 Conclusions ................................................................................................ 71 
7.2 Future Work ................................................................................................ 71 
 
Bibliography ...................................................................................................... 73 
 
  
 
 
 
13 
 
Chapter 1: Introduction 
1.1 Background and Motivation 
Leukocyte rolling adhesion is the movement of leukocytes across the interior 
walls of capillaries and venules with the final goal of reaching the site where it 
will extravasate and ultimately combat the infection. Therefore the 
understanding of this phenomenon is paramount in comprehending how our 
immune system works.  
Although this cellular behaviour has been thoroughly studied, it has never been 
approached from a biomechanical point of view. This was the idea behind the 
research conducted at Motlab in Tokyo University of Science. The goal was to 
try to shed a bit more light on this phenomenon that occurs in our body. 
The initial research carried out by Sayaka Nomura, was aimed to observe the 
rolling adhesion of leukocytes along straight microfluidic channels. Once the 
observation and capture of images through fluorescence microscopy was 
achieved, she analysed the images with a self-written programme on python. 
This programme analyses the speed, angular velocity and centre of mass of the 
rolling leukocyte and outputs the numerical values of these parameters. 
However, during the development of the research, one thing was experienced; 
there was a problem with the way leukocytes rolled in the channel. Due to the 
simplicity of the channel design and the physics that govern microfluidic flow, 
leukocytes rolled in random pathways and not in a constant area of the channel, 
making the analysis of the data non reliable. Due to the parabolic profiles of 
laminar flow, the conditions which govern the behaviour of the immune cells 
vary depending on the section at which the cell is located. Therefore, my work 
aims to solve this problem and create a device that could be used in other 
essays and experiments of the sorts. 
This type of microfluidic device is called lab on a chip and belongs to a realm of 
microfluidic technology that is increasingly being used in biomedical engineering 
thanks to the advantages it poses over the classical glassware experiments.  
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The device created and explained in this work consists of a microfluidic system 
with a hydrodynamic flow focusing stage which ensures cells will flow through a 
controlled centred section of our microfluidic channel, for an optimal observation 
and analysis of the rolling of leukocytes along the device. Thanks to the design 
of the microfluidic channel, both top view and side view of the movement of the 
cells is possible. 
The system created in this work, poses of great relevance due to all of the fields 
it may be used in and all the applications it may have. Rolling cell adhesion is 
not only studied in immunology, but also in cancer and thrombus research. It 
has been discovered that E-selectin mediated rolling facilitates pancreatic 
cancer cell adhesion (Shea, et al. 2017). There are many recent studies that 
explain the importance of rolling adhesion in these areas of medicine, therefore 
the development of a system that has the ability to mimic this movement in vitro 
is of great relevance when testing new therapies, drugs and experiments.    
This work was developed at the Tokyo University of Science during a 3 month 
stay as a visiting student in Motlab, a micro/nanoscale thermofluidics research 
group directed by Professor Masahiro Motosuke in Tokyo, Japan. 
1.2 Objectives 
The main objective of this work is to develop a system that solves the problem 
raised previously: non uniform, non-centred flow of leukocytes along the 
microfluidic channel. The system will be reusable and biologically active in order 
to be used systematically in leukocytic experimentation. 
The specific objectives are as follow: 
 Systematically review an extensive bibliography on microfluidics, rolling 
cell adhesion and lab on a chip. 
 Understand the state of the art in microfluidic and rolling cell essays. 
 Develop a system capable of centring a stream of leukocytes with the 
goal of observing rolling cell adhesion. 
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1.3 Content Outline 
The following document is divided into seven chapters and a bibliographical 
section. This is the introductory first chapter of the seven chapter dissertation. 
In Chapter 2: The Immune System, we review and analyse an extensive 
bibliography regarding the immune system, Leukocytes and rolling 
adhesion. Here we aim to explain all the relevant information needed to 
understand the underlying biological principles and phenomena related to the 
works presented in this dissertation. 
In Chapter 3: Microfluidics, we aim to explain what microfluidics is and relate 
the equations that govern microfluidic flow to our work. In this chapter many 
aspects of microfluidic dynamics are covered with the goal of providing the 
reader of this work, the relevant information for understanding how the system 
behaves. 
In Chapter 4: Simulations, a series of simulations performed on COMSOL, the 
multiphysics simulation software, have been included. This chapter is of 
extreme relevance because it helps us visualize and comprehend the principles 
that dictate the behaviour of the fluid and the system we aim to design. Here we 
can observe hydrodynamic fluid focusing by two methods: particle tracing 
and transport of diluted species. 
In Chapter 5: Materials and Method, I have included all the necessary 
information needed to build the system. The materials, machinery and process 
was depicted in this chapter and supported with pictures. Both the microfluidic 
and the biological aspects of this work have been included. 
In Chapter 6: Experimental Analysis, the information regarding experimental 
setup and results has been included, alongside a discussion for each of the four 
experiments performed. 
In the final chapter, Chapter 7: Conclusion, we conclude this dissertation and 
propose future lines of work.  
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Chapter 2: The Immune System 
2.1 The Immune System 
Like all mammals, humans possess a specialized system destined for the 
protection and the defence of our body; we refer to this mechanism as the 
Immune System. This complex is composed by very specialized cells that 
function inside very well organized anatomical structures. Therefore to 
understand the importance of these specialized cells we must study them in 
conjunction with the tissues and organs in which these cells interact with. 
If we go back in history, evolutionary speaking, our immune system was 
developed in order to combat the infections caused by viruses, bacteria, 
protozoa, fungus and helminths. These pathogens can be responsible for many 
infections both intracellular and extracellular, for which the response must be 
different. The immune system has developed a variety of appropriate defence 
mechanisms in order to fight off each of the different pathogens that infect us.  
In order to eradicate a pathogen that has infected its host, the immune system 
must first detect its presence and then take the necessary steps to destroy it. 
For the destruction of pathogens, the human body has developed diverse 
immune mechanisms which are both innate and adaptive; the difference rests in 
the fact that they use different methods to detect threats and infections. 
In order for the innate response to work, a series of molecular patterns that are 
present in same group pathogens must be detected. All members of a same 
animal species are born with an innate and immediate capacity of detecting and 
destroying numerous pathogens which we have not been in contact before. The 
innate immune response is very effective; however, it cannot protect us from all 
threats. The majority of pathogenic agents are single celled organisms that 
divide very quickly; therefore, they evolve at higher rates and evade the body’s 
innate response. In order to avoid this, vertebrates have developed a pathogen 
reconnaissance strategy which enables the detection of foreign agents that 
have never been encountered before. This defence mechanism is referred to as 
18 
 
the adaptive immune system. Lymphocytes are the cells which will be 
responsible for this adaptive immunity. 
Immune cells are the key players in our immune system, enabling detection and 
destruction of foreign pathogens. There are many types of cells, each with 
different functions and characteristics. However, their origin is similar. Immune 
cells, commonly referred to as white blood cells or leukocytes, originate from 
the bone marrow, a semi-solid tissue found in the trabecular bone tissue. In this 
myeloid tissue, leukocyte precursors are created. These “parent” cells will then 
differentiate through a process called haematopoiesis to create white blood 
cells.  
There are many types of cells in our immune system as seen in Figure 2.1, all 
with different characteristics but same objective: to destroy foreign pathogens.  
 
Figure 2.1: Leukocyte development, from progenitor to mature differentiated cells (Mikael Häggström 
2009). 
2.1.1 Haematopoiesis 
All blood cells arise from a type of cell called the hematopoietic stem cell (HSC). 
Stem cells are undifferentiated cells which have the unique capacity of 
differentiating into many other types of cells (see Figure 2.1). Also, they 
possess many different characteristics which enable them to self-renew 
themselves indefinitely and regulate their population by cell divisions (Kuby, et 
al. 1992). In humans, haematopoiesis begins in the embryonic yolk sac during 
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the first two weeks of development, by the third month, hematopoietic stem cells 
have migrated to the foetal liver; after that, the differentiation of HSCs in the 
bone marrow becomes the mayor factor in haematopoiesis. By birth there is 
little or no haematopoiesis in the liver and spleen (Kuby, et al. 1992, 23).  
The first step to haematopoiesis consists in the differentiation of a multipotent 
stem cell, creating either a myeloid progenitor cell or a lymphoid progenitor cell. 
These cells have now lost the capacity of self-renewal and are therefore 
destined to give rise to cells of its particular cell lineage. Lymphoid progenitors 
will then differentiate into Natural Killers (NK) cells, T lymphocytes and B 
lymphocytes. Analogously, myeloid progenitors will give rise to erythrocytes (red 
blood cells, RBCs), platelets, basophils, neutrophils and other immune cells 
commonly referred to as white blood cells. Each of these cells are created and 
induced under different circumstances, different signals and microenvironments 
will promote growth and differentiation of these cells. These microenvironments 
are occasioned by scaffold like structures created by stromal cells and by 
growth factors that arrive to their target cells by diffusion. To summarise, it can 
be said that the different cells that descend from the HSCs will come to be due 
to the different interactions of the different factors related with its growth and 
differentiation.  
Haematopoiesis is regulated at genetic level, the development of the stem cells 
into the different cell types requires the expression of different sets of lineage-
determining and lineage-specific genes at appropriate times and in correct order 
(Kuby, et al. 1992, 24). Therefore, we can say with certainty that the proteins 
expressed by these genes are of utmost importance and will determine the 
outcome of cellular differentiation. Much remains to be learnt in this field; 
however, there are some discoveries that have provided a very useful insight 
into understanding how this process works. One of these advances in the 
immune-genetic research led to the discovery of Leukocyte Adhesion 
Deficiency (LAD), a heritable genetic disease that we will discuss in the 
following pages due to the close relationship with our research. 
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2.1.2 Immune System Organs 
Like many other systems, the Immune system has distinct organs and tissues 
with specialized functions, destined to contribute to the development of immune 
responses. Immunologists classify these organs by function, dividing them into 
primary and secondary lymphoid organs. The thymus and bone marrow belong 
to the central o primary lymphoid organs, whereas the secondary lymphoid 
organs are comprised of lymph nodes, the spleen and other tissues. Maturation 
of lymphocytes takes place in the primary lymphoid organs, whereas in the 
previously mentioned secondary lymphoid organs, the matured lymphocytes 
interact with antigens. These lymphocytes will then circulate around the body 
through the circulatory and lymphatic system (Figure 2.2), detecting and fighting 
off possible pathogens. 
Primary lymphoid Organs 
Lymphocytes generated in haematopoiesis are yet to be matured and become 
committed to antigenic specificity. Only after the cell has matured within a 
primary organ, is the cell immunocompetent. T-lymphocytes are called as such 
due to the fact that they mature in the thymus, a primary lymphoid organ.  
The thymus is a specialized organ formed by specialized cells called 
thymocytes separated by connective tissue. This organ is the site for t-
lymphocyte development and maturation. The thymus is flat and bi-lobed, being 
located above the heart (see Figure 2.2), it is very complex and of utmost 
importance. Its role in the immune system can be studied in mice by examining 
the effects of neonatal thymectomy. Thymectomized mice show a dramatic 
decrease in circulating lymphocytes of the T-cell lineage and an absence of cell-
mediated immunity (Kuby, et al. 1992, 41).    
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Figure 2.2: Schematic of the Lymphatic System (Blaus 2013). 
The other primary lymphoid organ is the bone marrow. The bone marrow is a 
sponge-like tissue situated inside of bones; most of the cells of our immune 
system are produced and developed here and, once they develop and mature, 
they migrate to the bloodstream to circulate the body. At birth, many bones 
contain red bone marrow, which actively builds defence cells. During the course 
of life, more and more of this red bone marrow turns into fat tissue. Eventually, 
all the red bone marrow transforms, except in a few bones, such as the ribs, the 
breast bone and the pelvic bone (Schmidt, Lang and Heckmann 2010). 
Lymphocytes that originate from this organ are referred to as B-lymphocytes. 
Lymphatic System 
The circulatory system is a pressurised system, because of this as blood 
circulates the body, the plasma seeps through the capillary’s endothelium, this 
fluid is called interstitial fluid and bathes all the surrounding cells. Due to the 
high volumes of this fluid being permeated through the capillary walls, a 
lymphatic system needs to collect it to prevent swelling of the nearby areas 
(edema) which would slowly become life threatening. This lymphatic system 
forms a network of lymphatic vessels which collect all the lymph (plasma) and 
then drains it back into the blood. When a foreign antigen gains entrance to the 
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tissues, it is picked up by the lymphatic system and is carried to the lymph 
nodes where it is trapped and treated accordingly. 
2.2 Leukocyte Activation and Migration 
When we experience an infection from an external agent, our bodies react in 
many different ways to signal our immune system that the integrity of a tissue 
has been compromised. An inflammatory response is generated as a response 
to a local injury or trauma, which the immune system detects as a distress 
signal. This inflammation is a complex response that involves several immune 
system cells and numerous mediators. Once the innate immune system 
reaches the area of infection, it mounts the initial attack against the foreign 
pathogen. However this initial defence may not suffice and lymphocytes are 
recruited and become activated in response to antigens with the goal of helping 
in the battle against foreign pathogens. This process is very complex therefore 
we shall study it in more detail in the following pages. 
2.2.1 Cell Adhesion Molecules 
The human body is made out of many cells and tissues joint together forming 
bigger and more functional structures. All these cells are bonded together by 
what we call cell adhesion molecules (CAMs), and it is these same molecules 
that help the leukocytes and the immune system cells interact with other 
tissues.  
Leukocytes are circulating around the body waiting for an infection, ready to 
attack foreign pathogens. Therefore, vascular endothelium serves as an 
important entry point for these leukocytes to arrive at the targeted tissue. Due to 
the high pressure in the circulatory system, cells are under high mechanical 
stresses and find it impossible to attach themselves to the vascular endothelium 
and trespass the vascular barrier. Therefore, they need some sort of aid to 
migrate from the blood to the lymphoid organs or surrounding tissues. This 
process is called extravasation and it happens partly due to the presence of 
leukocyte specific CAMs that will bind white blood cells to the vascular walls. 
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Endothelial cells express leukocyte adhesion molecules, some are cell specific 
and others are response specific, e.g. cytokine produced during an 
inflammatory process. All in all, we can say that regardless the origin of the 
response or specificity; these CAMs are paramount in the migration and 
movement of white blood cells across the body. 
In addition to their role in leukocyte adhesion to vascular endothelial cells, 
CAMs on leukocytes serve to increase the strength of the functional interactions 
between cells of the immune system. Various adhesion molecules have been 
shown to contribute to the interactions between TH cells and APCs, TH and B 
cells, and CTLs and target cells (Stein and Nombela-Arrieta 2005). Most of 
these CAMs belong to four families of adhesion proteins: selectin1, mucin-like, 
integrin and the immunoglobulin family. 
Selectins 
The selectin family of cell adhesion protein are a group of glycoproteins that has 
a specific domain that enables biding with other molecules due to the affinity of 
this lectin-like domain to specific carbohydrates. The selectin protein family 
groups three molecules: L-, E- and P-selectin. E- and P-selectin are mostly 
found on vascular endothelium whereas L-selectin is expressed on the surface 
of most leukocytes. E-selectin is a very interesting protein that needs synthesis 
of new proteins for it to express itself on the vascular walls. These new proteins 
commonly appear after the stimulation of inflammatory cytokines. Selectins are 
the initial bonders of leukocytes to vascular endothelium; therefore they play a 
prominent role in leukocyte extravasation. 
Chemokines are another family of proteins relevant in leukocyte extravasation, 
these molecules are responsible for certain CAMs activation, e.g. E-selectin. 
Consequently they are a mayor regulator in lymphocyte and leukocyte traffic 
(Stein and Nombela-Arrieta 2005). Chemokines are typically induced due to an 
inflammation process, commonly as a response for tissue infection. These 
molecules are of high importance because they essentially activate E-selectin 
                                            
1
 Due to the importance of selectin family adhesion protein in our research we shall only focus 
on this protein for the time being. 
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molecules. In the event of chemokines not being expressed, leukocytes would 
not be correctly recruited due to E-selectin not being activated (Collins, et al. 
1991). 
2.2.2 Leukocyte Extravasation 
Lymphocyte and Leukocyte extravasation as a whole is a multistep process that 
occurs in blood vessels and regulates the traffic of white blood cells in the body. 
This process is normally initiated by an inflammatory response due to the 
infection of a tissue by a foreign agent. Once this inflammatory response 
develops, cytokines and other inflammatory mediators act on the local blood 
vessel walls, inducing the expression on endothelial CAMs. Once the site is 
activated, leukocytes can then proceed to extravasate to the site of infection. 
For this to happen, leukocytes will have to strongly attach themselves to the 
vessel wall to avoid being swept away by the highly pressurised flow of blood. 
Leukocyte extravasation can be divided into four steps: leukocyte rolling, 
activation, arrest and migration. We shall focus on the rolling phase of the cell’s 
movement. Rolling is mediated by selectins; this movement is comprised of a 
loosely attached bond that will bind the cell to the endothelium by a low-affinity 
selectin-surface carbohydrate interaction. As we’ve mentioned previously, E-
selectin is activated by chemokines, therefore once they are properly expressed 
in the endothelium they can adhere to carbohydrates expressed in leukocyte 
membranes. Being such a weak adhesion, leukocytes will only bond briefly and 
soon detach itself due to the shear force of the circulating blood. Once this 
happens it will rapidly attach itself to another endothelial cell. This tumbling of 
the cell is repeated over and over, creating a rolling motion (see Figure 2.3). 
This process is fairly slow; therefore it slows down the speed of the cell just 
enough to allow interactions between chemokines present in vessel wall and 
the receptors on the leukocyte surface to interact and generate a tighter bond 
that will completely adhere the cell to the wall. Once the movement of the 
leukocyte has been stopped by this tight adhesion, the cell will squeeze through 
two neighbouring endothelial cells and traverse the endothelial barrier and enter 
the infected tissue (Anderson and Anderson 1976).  
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Figure 2.3: Steps in Leukocyte (Neutrophil) extravasation (H. Shaz, R. Stowell y D. Hillyer 2011). 
2.2.3 Leukocyte Adhesion Deficiency 
Leukocyte Adhesion Deficiency or LAD is a genetic disorder that is 
characterized by a poor leukocyte adhesion to the capillary walls, making it 
impossible for the immune system cells to adhere properly and therefore not 
extravasate to the infected tissue. This disease results in the immunodeficiency 
of the patient and concludes in the patient having recurrent infections.  
LAD affected patients will suffer from bacterial infections from a very early age 
and can become a life threatening condition due to the infant’s inability to 
combat foreign pathogens. This inability to combat bacteria and other agents is 
due to the non-existing leukocyte migration. Besides the notable absence of a 
defence system, LAD patients will also have high counts of leukocytes in the 
blood and will not be able to form pus (Abbas, Lichtmann and Pillai 2012). 
As we speak there is no cure for this disease, the only current curative therapy 
is intensive antibiotherapy or haemopoietic stem cell transplant. I wanted to 
include this section in this chapter because although there is no cure, the 
prototype and experiment that we propose in this work could be used as a tool 
to conduct experiments and assays to design a novel drug and, eventually, test 
its suitability for curing this disease. 
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Chapter 3: Microfluidics 
3.1 What is Microfluidics? 
Microfluidics is a technology that is given on submillimetre scales: microfluidics 
studies the interactions of fluids in channels with microscopic dimensions. This 
area of fluidics is providing a new environment in which we can carry out 
numerous experiments and will continue to do so in the following years, making 
it a very promising technology that will be used in multiple fields of science and 
research. 
Historically, microfluidics became widely used after the end of the cold war. Due 
to the military and terrorist threats chemical and biological weapons posed, 
scientists realized microfluidics could be used on this field; therefore, the 
Defence Advanced Research Projects Agency (DARPA) of the US Department 
of Defence supported a series of programmes in the 1990s aimed at the 
development of microfluidic systems for field-deployable chemical and biological 
threat detection. These programmes were the main stimulus for the rapid 
growth of academic microfluidic technology (Whitesides 2006). 
In vitro microfluidics take place in a series of structures called microfluidic 
channels that manipulate low volumes of fluids (10-9 to 10-18 litres). These 
channels are designed and characterised using technologies borrowed from the 
field of electronics and microelectronics and are normally in the range of 
hundredths of a micron. Within these channels, diverse fluids flow and interact 
with each giving microfluidic chips their incomparable advantage. These chips 
are designed in order to analyse, synthesize chemicals and re-enact diverse 
phenomena, they are becoming a tool that is increasingly being used due to 
their ability of performing all these processes with the following advantages: low 
cost, short reaction times, low reagent volume and increased performance. 
Besides the aforementioned advantages, the two main advantages microfluidics 
exhibit are their small size and their laminar flow, this last one being of extreme 
importance. 
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3.2 Properties of Fluidics 
There are certain important intrinsic properties we should highlight and discuss 
in this introductory section; they are presented in the following lines. 
 Mass density (ρ; Kg/m3): It is the mass distribution over a unit volume. 
 Specific volume (V; m3 /Kg): It is the volume occupied by a unit mass. 
 Weight density or Specific weight (γ; N/𝑚3): It is the force due to gravity 
on the mass in a unit volume and is expressed as: 
 𝛾 = 𝑔 · 𝜌 . (3.1) 
 Specific gravity or Relative density (δ): it is the ratio of density of the fluid 
to the density of water. 
 Viscosity: It is the resistance offered by the fluid to gradual deformation 
by neighbouring fluid layers under an external force, namely shear stress 
or tensile stress. 
 Dynamic Viscosity (η; 𝑃𝑜𝑖𝑠𝑒𝑢𝑖𝑙𝑙𝑒 (𝑃𝐼); 𝑃𝑎 · 𝑠): It is the resistance offered 
by a fluid layer to adjacent layers where all the layers are moving parallel 
to each other but at different speeds. Thus, is also called shear viscosity. 
Therefore, when top layer is moving slow, then ideally all the layer will be 
parallel to each other and speed of layers will be ‘zero’ in the bottom 
layer and maximum in the top layer. Here, each layer will oppose the 
forward motion of the layer above it and make the layer beneath it to 
move forward. In such conditions, an external force will be required to 
overcome the fluid viscosity and keep it in motion. This force is Newton’s 
shear force (Dixit and Kaushik 2016).  
 𝐹 =
η A U
𝑦
 . (3.2) 
These properties are given in all fluids and the alteration and difference 
between them will alter significantly the behaviour the fluid will exhibit. 
Therefore by understanding the intrinsic properties of a fluid, we will be able to 
design better microfluidic systems that behave as we expect them to behave, 
giving optimal results. 
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3.3 Shear Stress 
Due to the viscosity of real fluids, the friction caused by the boundary 
conditions, in essence, the channel walls will cause a shear stress on the 
border. The no-slip condition dictates that the speed of the fluid at the boundary 
is zero, but at some height from the boundary the flow speed must be equal to 
that of the fluid (Day 1990). In Newtonian unidirectional fluids flowing in a 
laminar manner, the shear stress is given by the following formula: 
 𝜏(𝑦) = 𝜇
𝜕𝑢
𝜕𝑦
 , (3.3) 
where 𝜇 is the dynamic viscosity, 𝑢 the flow velocity and y the position along the 
width of the channel. 
To be precise, the wall shear stress is defined as: 
 𝜏𝑤 ≡ 𝜏(𝑦 = 0) = 𝜇
𝜕𝑢
𝜕𝑦
 |
𝑦=0
. (3.4) 
Let us note that the channel wall is where the highest shear stress is 
manifested. 
3.4 Types of Fluids 
When it comes down to fluids there are two main classifications: Newtonian and 
Non- Newtonian fluids. These fluids have different characteristics due to their 
different properties. It is important to study the types of fluids and their 
implications, because they can hugely impact the way we work with them on a 
microfluidic scale. 
Viscosity is proportional to shear stress and shear rate. Therefore the two types 
fluids are categorized into are given by the relation between viscosities. If the 
viscosity is constant the fluid will be a Newtonian fluid. On the contrary, if the 
viscosity changes, the fluid will be a non-Newtonian fluid. Some examples of 
Newtonian fluids include: water, alcohol, glycerol, honey… These fluids are only 
temperature dependant meaning, they will only change their viscosity with the 
action of temperature. 
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However the majority of fluids are Non- Newtonian, their viscosity changes due 
to shear rate or shear stress, making viscosity a very important factor in fluidics. 
In our case, this study will only work PBS. PBS is an aqueous mixture which 
contains sodium chloride (common salt) and disodium hydrogen phosphate in 
proportion to the concentrations present in the human body making it 
Newtonian fluid. 
3.5 Types of Flows 
In fluidics there are two types of flow: Laminar and Turbulent. These two types 
of flow are given, among other, by the trajectory of particles. 
Turbulent flows have the characteristic that the particles do not follow a straight 
path, their movement is chaotic. However when we analyse the flow in, say, a 
pipe, the average speed of the particles is the same making the flow profile a 
straight line. 
However, in laminar flow this does not happen. Laminar flows behave in such a 
way that causes the flow to exhibit a parabolic profile. 
Note that these two flows can be more or less laminar or turbulent depending 
on the values of the parameters that characterize the Reynolds number, as we 
will see in the following section. 
3.5.1 Laminar flow 
The flow of the fluid through a microfluidic channel can be characterised by the 
Reynolds number, defined as: 
 𝑅𝑒 =  
𝐿 𝑉𝑎𝑣𝑔 𝜌
𝜇
 , (3.5) 
where 𝐿 is the length, 𝑉 is the average velocity of the flow, 𝜌 is the density of 
the fluid and 𝜇 is the viscosity. Here the most relevant number is 𝐿 due to the 
small dimensions of the channel, therefore the Reynolds number will always be 
much less than 100 making it a laminar flow. 
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Flow in microfluidics exhibits laminar flow as opposed to macroscopic fluidic 
systems that usually behave in a turbulent manner. This turbulent flow is chaotic 
and violent, making particles move along the channels in an erratic and random 
manner (see Figure 3.1). Turbulent flow in microfluidics is most of the time a 
disadvantage rather than a beneficial factor, this is because these types of flows 
are very hard to control and even harder to model, and therefore are practically 
never used as opposed to laminar flows.  
 
Figure 3.1: Illustration depicting the difference between laminar flow and turbulent flow. 
Microfluidic devices mostly behave in a laminar manner. In laminar flow each 
particle along the width of the channel travels in a straight path and do not 
interfere in the other particle’s movement, this is shown in the absence of 
turbulence, as previously mentioned. However due to the near perfectly linear 
motion particles have and their viscosity component, a new effect arises: 
parabolic flow profile. 
Fluids have different grades of viscosity, this viscosity is nothing more than the 
resistance a particle has to the flow of the fluid. This viscosity affects the fluid 
particles and makes them more prone to interacting with its neighbouring 
particles. This is why there is a gradient of velocity in laminar flow. The walls of 
the channel are fixed therefore the frictional force between the channel wall and 
the fluid is highest cause the particles in this domain of the channel to barely 
move. This effect alters the behaviour of all the particles creating a parabolic 
profile which has its peak velocity in the central section. If we observe Figure 
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3.2, we can clearly see this behaviour in a straight channel. In this figure, the 
flow in the central section has a maximum velocity as opposed to the lateral 
sections where a substantial decrease in velocity is observed. 
 
Figure 3.2: Parabolic profile in a fluid flow simulation (COMSOL). 
This behaviour disrupts the way in which we calculate the speed of the flow. 
However through mathematical analysis we can extrapolate the equation that 
governs the flow. 
 𝑢(𝑟) = 2 𝑉𝑎𝑣𝑔  (1 −
𝑟2
𝑅2
) , (3.6) 
 
 𝑉𝑎𝑣𝑔 =  −
𝑅2
8𝜇
 (
𝑑𝑃
𝑑𝑥
) , (3.7) 
where 𝑟 equals the distance from the middle point and 𝑅 is the radius of the 
pipe the fluid flows through. 
3.6 Hydrodynamic Focusing 
Hydrodynamic focusing is also called flow focusing or sheath flow, however 
many names it may have, they all have one underlining function: to force a fluid 
or cell to pass through a specified section. This technique has been used for 
many years in the realm of fluid dynamics to control the way we interact with the 
different phases of a fluid in a closed environment. Hydrodynamic focusing has 
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been widely used in many applications as in flow cytometry (Shuler, Aris and 
Tsuchiya 1972). 
 
Figure 3.3: Flow focusing structure. 
A flow focusing device is mainly composed of three inlets and one outlet as 
seen in Figure 3.3. The flow focusing method has the goal of placing a stream 
of fluid or solid phase materials in the central portion of the channel by the use 
of the auxiliary side channels. When the central channel which flows at a lower 
pressure, arrives at the junction point, the fluid that comes in from the auxiliary 
inlets pushes the central interface into a determined section, which will be fixed 
by the pressure at which the focusing fluid is flowing at.  
This phenomenon and tool widely used in microfluidics is due to the 
conservation of Energy and Mass law. 
3.6.1 Conservation of Energy 
Energy within a fluidic system remains constant in such a way that energy 
acting on the system is continuously changed in to other forms such as work. 
For fluids the equation that governs this principle is very complicated, due to 
fact that is taken in consideration several forms of energy acting and dissipating 
out of a defined body. In its simplest form it can be described as: 
 ∆𝐸 = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 . (3.8) 
This has certain ramification such as the conservation of volumetric flow rate. 
 
𝑄(𝑣𝑜𝑙𝑢𝑚𝑒𝑡𝑟𝑖𝑐 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒) = 𝑣 · 𝐴 , (3.9) 
where 𝑣 is the velocity of the flow in 𝑚/𝑠 and 𝐴 is the cross sectional area. 
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This formula explains that in the presence of a bottleneck, the cross sectional 
area will decrease and therefore increase the speed at which the flow is flowing. 
3.7 Lab on a Chip 
Lab on a Chip or “LOC” is a term used to describe a specific use of 
microfluidics. As explained in the introductory section of this chapter, 
microfluidics came to be due to the need of having a quick and small field 
deployable device to detect certain chemical agents in the air. This initial goal of 
miniaturization has been extrapolated to other applications creating the field of 
LOC. LOC tries to synthesize all the necessary analytical tests that would be 
needed to perform certain laboratory analysis on a silicone chip the size of a 
coin as seen in Figure 3.4. 
Lab on a chip microfluidic devices are being developed to be used in many 
different industries, with the goal of making chemical analysis much faster, 
cheaper and precise (Whitesides 2006). One of the said industries is 
healthcare. Hospitals perform thousands of tests on a daily basis, costing them 
a lot of resources and money on personnel and equipment. LOC devices offer a 
very promising future where certain clinical testing can be made accessible and 
affordable to those healthcare facilities that cannot afford traditional glassware 
laboratories. 
 
Figure 3.4: Example of microfluidic lab on a chip device. This device aims to perform chemical analysis 
using microfluidic and MEM technology (Shutterstock). 
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3.7.1 Organ on a chip  
Another emerging area where microfluidics is being used would be biological 
emulation. Laboratories worldwide are trying to replicate the phenomena that 
occur in our bodies with the use of microfluidic technology (see Figure 3.5). 
These devices are referred to as “Organs on a chip”. With these organs on a 
chip, researchers aim to study how our body works and how they could behave 
under the use of certain drugs and diseases. 
 
Figure 3.5: Emulate Lung on a chip microfluidic device. This device aims to provide a medium in which we 
test new therapy drugs. 
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Chapter 4: Simulations 
4.1 Introduction 
Computer simulations and CAD software has become an increasingly used 
technology in engineering, due to the advantages of working in a virtual 
environment. This chapter contains the simulations performed on COMSOL that 
were necessary for the development of this research. Simulations were used 
and are needed in this research because they pose a cheap and accessible 
environment where we can perform tests on our prototypes before building the 
physical models; these models give a deep understanding of the possible 
behaviour of our device. 
The software of choice was COMSOL, a Multiphysics modelling software which 
allows simulating microfluidic and creeping flows. 
4.2 Simulations 
4.2.1 Fluid Flow Simulation 
This section corresponds to the simulation of a viscous fluid along a microfluidic 
channel in a laminar flow. The cross section of the channel is 50 μm x 100 μm. 
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Figure 4.1: Fluid Flow simulation 50 μL/h XZ plane visualization. The units expressed in the legend are 
m/s. 
As we can observe in Figure 4.1, where velocity contours at different 
longitudinal locations are show, the flow is faster in the central portion rather 
than on the sides, this is the well-known effect of the symmetrical parabolic fluid 
profile. The average velocity is given as: 
 𝑣𝑚 =
1
4𝜂
 
∆𝑃
∆𝑥
 𝑅2 , (4.1) 
where, 𝜂 is the dynamic viscosity, ∆𝑃 the difference of fluid pressure, ∆𝑥 the 
distance covered and 𝑅 half the width of the channel. 
While the velocity at a given point is defined by the following formula: 
 𝑣(𝑥) = 𝑣𝑚  [1 −
𝑥2
𝑅2
] , (4.2) 
where 𝑣𝑚 is calculated in Formula 4.1, 𝑅 is half of the width of the channel and 
𝑥 is the position along the perpendicular axis to the flow of the fluid. This effect 
of faster fluid at the centre of the geometry is given by the wall friction with the 
flowing fluid. 
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Figure 4.2: Fluid Flow simulation 50 μL/h YX plane visualization. The units expressed in the legend are 
m/s. 
 
As we can observe in Figure 4.2 and Figure 4.1 where the flow is faster in the 
central section, this effect is given in both the 𝑥 and the 𝑧 direction, this is due to 
the presence of side walls in both these axes. In the following figure (see Figure 
4.3) we can perfectly observe how the speed varies in the different 𝑥, 𝑦 and 𝑧 
coordinates. Due to the laminar flow and dynamic viscosity the profile of our 
flow will be parabolic. For this simulation we used particle tracing physics to 
clearly represent the different speed and their distribution along the channel.  
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Figure 4.3: Parabolic profile of a laminar flow in a rectangular channel. 
 
4.2.2 Sheath Flow Simulation 
These following simulations try to show the effect of the sheath flow in a 
microfluidic channel.  
In Figure 4, the total flow in the central, post focusing stage is 50 μL/h; in this 
plot all three inlets have the same flow rate: 16.67 μL/h, as given by the 
following formula. 
 𝑄𝑡𝑜𝑡𝑎𝑙 = 𝑄1 + 𝑄2 + 𝑄3 . (4.3) 
𝑄1, 𝑄2 and 𝑄3 correspond to the different inlets of the microfluidic hydrodynamic 
focusing device; by altering the different inflow rates of these inlets we will have 
different focusing widths in the post-focusing section.  
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Figure 4.4: Surface plot of the fluid velocity. Speed measured in m/s. 
 
In Figure 4, we can observe the surface plot of the fluid velocity. Each of the 
inlets have the same flow rate: 4.63 x 10-12 m3/s or 16.67 μL/h. The total flow 
rate in the central channel is 50 μL/h. We immediately see that in this central 
channel, the velocity magnitude is much greater. Flow rate in a pipe is given by 
fluid speed multiplied by the area of the channel cross-section:   
 𝑄 = 𝑣𝑎𝑣𝑒𝑟𝑎𝑔𝑒 × 𝐴𝑐𝑟𝑜𝑠𝑠−𝑠𝑒𝑐𝑡𝑖𝑜𝑛 . (4.4) 
 
 𝑣𝑎𝑣𝑒𝑟𝑎𝑔𝑒 =
𝑄
𝐴𝑐𝑟𝑜𝑠𝑠−𝑠𝑒𝑐𝑡𝑖𝑜𝑛
 . (4.5) 
 
Therefore, while the cross sectional area remains constant we see a threefold 
increase in volumetric fluid flow rate. 
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Figure 4.5: Sheath flow visualized. In this simulation Transport of Diluted Species was used as a form of 
simulating dye. The inlet speeds are all equal. 
In the simulation viewed in Figure 4.5, COMSOL was used to show a 
representation of the future sheath flow developed. For this image I used the 
Transport of Diluted Species physics. Applying a fine meshing and a low 
diffusion coefficient we obtain this image where we can clearly observe the 
distribution of chemicals and therefore estimate the future behaviour of our 
sheath flow. 
The same method was used to simulate the configurations shown in Figure 4.5 
and 4.6. The speeds were varied in both simulations to show the way the 
sheath flow will behave with a higher flow rate through the side inlets. As we 
can see in Figure 4.6 and Figure 4.7, the higher the speeds through the sheath 
flow, the smaller the flow focusing area. Therefore, we will be able to focus 
leukocytes with a higher precision. 
Using this information, we can measure approximately the width of the sheath 
flow and select a few promising data sets for further experimentation.  
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Figure 4.6: Sheath flow visualized. The inlet flow ratio is 1:2. Legend expresses concentration. 
 
 
 
Figure 4.7: Sheath flow visualized. Flow ratio 1:12. Legend expresses concentration. 
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4.2.3 Particle tracing sheath flow Simulation 
In this section, a new set of simulations were designed with the goal of verifying 
the information obtained in the previous section. Particle tracing physics was 
used to track the possible flow of leukocytes along my device. COMSOL was 
the software of choice due to its many possibilities. This software enables to 
recreate the physics governed in the flow of particles with the possibility of 
changing diverse parameters such as particle diameter, particle density, particle 
release, forces acting on the particles, etc. 
 
Figure 4.8: Sheath flow visualized with particle tracing physics. Flow rate 1:4. Max flow rate 45.5 μL/h. 
In Figure 4.8 we can observe a simulation showing the effect on particles when 
using a hydrodynamic flow focusing section. The particles will flow with a 
parabolic profile as observed previously and once they are focused with a 
sheath flow, the particles will be located in the central section of the channel. It 
was estimated that with a total flow of 45.5 μL/h in the central channel and a 1:4 
flow rate (central inlet: 5.05 μL/h), we can achieve a 15 μm centre sheath that 
will satisfy the needs of our experiment. 
Finally to visualize the results of our design a 3D time dependant simulation 
was performed. In Figure 4.9 we can see a time lapse where the movement of 
particles in our device will behave. As we can clearly see, the particles will be 
focused in the central section. In this figure, each figure represents a 0.5 
second increment 
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Figure 4.9: Time lapse, simulated on COMSOL with the aid of particle tracing physics configuration. The 
increments represented are of 0.5 s. 
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4.2.3.1 Particle parameters 
Particle type Solid particles 
Particle density 1077 kg/m3 
Particle diameter 10 μm 
Number of particles per Release 500 
Table 4.1: Particle parameters for COMSOL Particle tracing for fluid flow physics (Zipurski, et al. 1976). 
In Table 4.1 we can observe the parameters used in the COMSOL particle 
tracing physics for fluid flow. All the data used to mimic the properties of 
leukocytes in our simulation was extracted from Zipurski’s paper (Zipurski, et al. 
1976). 
4.3 Discussion 
By conducting these simulations we have observed the flow of a fluid in our 
squared channel, we have studied the way particles will behave and interact 
and finally proved that our design is feasible and would give us the results we 
desire. However, we must never forget that simulations are always ideal 
situations, in real experimentation many interferences and errors might occur, 
such as the existence of bubbles in the microfluidic device. These results give a 
firm ground on which to lay our thoughts and future experimentation. In chapter 
6 we will discuss the experimental results and compare them to the ones 
obtained in this chapter. 
  
47 
 
Chapter 5: Materials & Method 
5.1 Rolling Cell Adhesion Microfluidic Device 
Microfluidics can be used in a variety of fields as previously mentioned; their 
usability extends to many areas in science. In our case the use of the 
microfluidic channel will be used to help us understand a little bit further about 
the rolling cell adhesion phenomenon therefore, our microfluidic channel must 
simulate a blood vessel. For this we have built several designs we will now 
demonstrate.  
5.2 Channel Geometry 
For us to observe the rolling cell adhesion phenomenon, we shall pump a fluid 
containing a mixture of lymphocytes and Phosphate Buffered Saline (PBS) 
Solution into the microfluidic device. Our device has been built in such a way 
that due to the coating of the substrate and the geometric shape of the channel 
we will be able to see and study the rolling of lymphocytes through the 
microscope.  
The channel has a squared section to easily control the wall shear stress that 
each section will be subject to. The channel has been designed with an 
absence of 90º corners to prevent flow alteration so that there is no induced 
mixing throughout the length of the channel, as seen in Figure 5.1. The key 
feature of the device was the use of a sheath flow or flow focusing technique, in 
order to control the interface of cells in the centre portion of the channel. 
 
Figure 5.1: AutoCAD render of the microfluidic device. 
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5.3 Microfabrication Technology 
For the development of this microfluidic device, the standard microfluidic 
protocol was used. Firstly, a photomask was developed using microfabrication 
technology, then several Silicon wafers were produced by photolithography, 
lastly, PDMS was poured on onto the Silicon wafers and cured to produce the 
resulting microfluidic channel. 
5.3.1 Electron Beam Lithography 
As it is the case with almost all of microfluidic technology, this technology was 
firstly developed for electronics applications, however due to the capacity of 
achieving very high resolutions it may be used in several different applications. 
This technique consists in performing patterns on a substrate using an electron 
beam. This photomask is then used in the successive stages of the 
development of microfluidic channels. The photomask was developed at the 
University of Tokyo, Takeda Tipezaki Building Clean Room by the student 
Sayaka Nomura of the Tokyo University of Science. 
5.3.1.1 Photomask Creation 
 
 
Figure 5.2: Electron Beam Schematic showing the process of characterization of a photomask. 
As illustrated in Figure 5.2, the different steps to making the photomask are: 
1. Initially, the photomask (see Figure 5.2) is covered in a special photoresist 
that when in contact with the electron beam will draw the desired pattern onto 
the mask (see Table 5.1). This part is critical in the development of the mask, 
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an incorrect exposure to the photoresist will conclude in an inaccurate master 
photomask that will then influence in a negative manner the rest of the process. 
For this section of our process the machine shown in Figure 5.3 was used, with 
the parameters shown in Table 5.2, respectively. 
Each resist has specific curing parameters and a required energy per unit area, 
therefore the amount of light and exposure time must be adjusted accordingly to 
the resist used. An incorrect adjustment of these specifications could result in 
an insufficient chromium removal of the underlying layers. 
Manufacturer Toppan 
Model ST-TLR6-TQZ-5009(5T) 
Mask depth 2.3 mm 
Resist ZEP7000 
Resist depth 3000 Å 
Prebaking 190 ºC for 30 minutes 
Metal layer Cr / CrO2 
Metal Layer depth 100 nm 
Table 5.1: Photomask Specification. 
 
Figure 5.3: Electron Beam Lithography equipment used for the creation of the photomask. This system is 
located in Tokyo University. 
Manufacturer Advantest 
Model F5112 
Smallest dimension possible 100 nm 
Dimension deviation 3σ ≤ 15 nm 
Superposition precision 
|mean value| + 3 σ 
≤ 40 nm 
Table 5.2: Specification of the Advantest Electron Beam System. 
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2. Once the resist has been exposed to the electron beam, it has to be 
developed and then rinsed off. Isopropyl alcohol (IPA) and methyl isobutyl 
ketone (MIBK) are the chemicals used in this process. The machine EVG 101D 
Automatic Developer was used for this step (see Figure 5.4) (see Table 5.3). 
 
Figure 5.4: Automatic photomask developing system. Located in Tokyo University. 
 
Manufacturer EVG 
Model 101D 
Spin module max. deployment num. 1 
Types of Development 
Pressure tank, flow control, nitrogen 
nozzle for spay developing, paddle 
developing, rinse developing 
Table 5.3: Automatic Photomask Developer technical Specifications. 
3. This step is called Etching. Etching consists in using strong acids and 
chemicals to cut or produce a pattern into the unprotected parts of a metal 
surface. In our case, we immerse the mask into a chemical solution with the 
goal of removing the exposed metal and thus forming our pattern. In some 
cases Plasma Ashing is used as a method to pre-treat the surface for a better 
etching process.  Using a plasma source, Plasma Ashing is performed onto the 
photoresist to enable a better penetration of the chemicals used in the later 
etching process. The ashing apparatus used was the FA-1 manufactured by 
Samco (see Figure 5.5) (see Table 5.4). The etching apparatus used was the 
Fairchild 1140 etching machine (see Figure 5.7) (see Table 5.5) 
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Figure 5.5: Ashing apparatus located in Tokyo University. 
 Manufacturer Samco 
Model FA-1 
Gas 
CF4 (50 sccm) 
O2 (50 sccm) 
Maximum RF 200 W 
Table 5.4: Ashing apparatus technical specifications. 
4. Finally, we wash off the resist with an ashing device (see Figure 5.6); 
consequently, all the resist is removed from our mask leaving behind a 
Chromium Oxide layer on top of a glass substrate, with a pattern that will then 
be used throughout the whole microfluidic device fabrication. 
This process previously explained will lead to the creation of a photomask (see 
Figure 5.6). The photomask has a series of patterns etched into the glass-metal 
surface which are transparent, this will enable light to pass through and thus 
create the shape of the device we desire.  
 
Figure 5.6: Photomask used in the microfluidic channel development, created by Sayaka Nomura in 2015. 
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Figure 5.7: Etching apparatus, located in Tokyo University. 
 
Manufacturer Fairchild 
Model 1140 
Output Power 3.6 kW 
Supply Pressure 
CDA 80PSI 
N2 60 PSI 
D1water 30PSI 
Discharge Condition 
80SCFM 
20SCFM 
Table 5.5: Technical specifications of the etching machine. 
 
5.3.2 Photolithography 
We call photolithography the process in which we use UV light to cure 
photosensitive chemicals in order to make patters on a wafer. Just like the 
previous technology, this proceeding was borrowed from the electronics field. In 
electric and electronic engineering, photolithography is used in the 
manufacturing of transistors and complex integrated circuits. 
In this process, we shall use the photomask fabricated in the previous section 
and use it for patterning of a silicon wafer, this silicon wafer will be the master 
mould we will then pour our PDMS solution on to build the channel. 
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5.3.2.1 Silicon patterning procedure 
 
Figure 5.8: Master mould lithography process. 
As illustrated in Figure 5.8, the different steps to manufacturing the silicon wafer 
microfluidic channel master mould: 
1. The first step in photolithography is to apply a coating of photoresist to our 
silicon wafer. In our case we used SU-8 photoresist (see Figure 5.9) due to its 
chemical attributes (see Table 5.6). 
 
Figure 5.9: SU-8 photoresist. 
Manufacturer Micro Chem. 
Model SU-8 3000 
Adhesive strength 71 MPa 
Glass transition point 198 ºC, DMA tan δ 
Volume Resistivity 1.8 x 1016 Ω·cm 
Water Absorption 0.5 % 85 ºC / 85 %RH, 120h 
Table 5.6: Chemical Specifications of Su-8 photoresist. 
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In order to apply the photoresist we first pour the solution onto a silicon wafer 
and we spin it at a rate of 2250 rpm (see Table 5.7) with the use of the spin 
coater (see Figure 5.10), this spinning will extend the SU-8 over the entire 
silicon wafer achieving a thickness of 50 μm. We then prebake the silicon wafer 
using a hot plate at 60 ºC for 1 minute and then at 90 ºC for 15 minutes. After 
heating, we leave to cool down in room temperature.  
 
Figure 5.10: Spin coating apparatus located in Motlab, Tokyo University of Science. 
Manufacturer Active 
Model ACT-220D 
Rotation range 200 ~ 8000 rpm 
Rotation revolutions ± 3 rpm 
Vacuum 350 Torr 
Steps / patterns 10 steps / 100 patterns 
Table 5.7: Technical specifications for spin coater. 
 
2. The next step consists of exposing the spin coated silicon wafer to a UV light 
to generate the pattern on our wafer. For this we use the photomask aligner 
(see Figure 5.11). This machine will expose our silicon wafer to a UV source 
with the shape of the photomask, for this to happen UV light is emitted through 
the source (see Table 5.8) and only passes through the photomask in the areas 
where the Chromium Oxide has been etched out in the previous process. Once 
the photoresist is cured with UV light, we can proceed to the development of the 
SU-8. After the exposure, we perform a post-bake by heating on a hot plate the 
Si wafer at 60 ºC for 1 minute and 90 ºC for 15 minutes.   
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Figure 5.11: Mask Aligner apparatus, located in Tokyo University of Science. 
Manufacturer Nanotec 
Model ES20tr 
Exposure area 105 mm 
Illumination uniformity ±5 % 
Illumination distance 200 mm 
Dominant Wavelength 365, 405, 436 nm 
UV irradiation strength More than 35m W/cm2 (at 365 nm) 
Table 5.8: Technical specifications of Nanotec mask aligner. 
 
3. Finally, we proceed to develop the silicon wafer by rinsing and immersing the 
wafer into SU-8 developer. In some cases, SU-8 will remain; therefore, we will 
wash the wafer with isopropanol, acetone, ethanol and distilled water. 
Once we have completed all this process we will have correctly developed a 
silicon wafer with our pattern drawn on it (see Figure 5.12). 
 
Figure 5.12: Silicon wafer microfluidic channel master mould. 
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5.3.3 PDMS Channel 
For the characterisation of the microfluidic channel, we used PDMS (Figure 
5.13). PDMS is a widely used silicon-based organic polymer in microfluidics; 
this polymer is used due to its many advantages. As a result of its flexibility and 
its mechanical properties this type of technological procedure is also referred to 
as soft lithography. 
 
Figure 5.13: PDMS. 
In order to create our PDMS channel, we will simply pour the mixture of PDMS 
on our SU-8 mould and leave to dry up until forming a solid block. The mixture 
we pour is a 10:1 PDMS to curing agent ratio (Table 5.9). Note that before 
pouring the PDMS onto the wafer we should place the mixture into a vacuum for 
40 minutes to remove all bubbles. 
Manufacturer Dow Corning Toray 
Model Silpot 184 
Viscosity 5000 cSt 
Density 1.11 g/cm3 
Mixing Ratio Main Agent: Curing Agent 10:1 
Heating temperature and time 60 ºC 80 minutes, 150 ºC 30 minutes 
Refractive Index 1.41 
Table 5.9: PDMS chemical specifications. 
Once we pour the PDMS we heat at 60ºC for 80 minutes and 150 ºC for 30 
minutes respectively. When dry (see Figure 5.14), we can simply cut with a 
razor blade, punch holes into the inlet and outlets and place on a clean glass 
slide to perform our experiments and tests. 
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Figure 5.14: Final microfluidic PDMS channel before assembly. 
5.4 E-Selectin substrate preparation 
The cell adhesion molecule used in this work is the E-selectin (see Figure 5.15) 
therefore we must coat the substrate of the channel for our setup to work 
properly. The preparation method is fairly simple due to the characteristics of 
the materials used (see Table 5.10). 
 
Figure 5.15: E-selectin. 
First we coat our glass slide with a fine layer of PDMS, for this we must spin 
coat the PDMS on the glass substrate. Thanks to the functional amino group of 
the E-selectin, we can easily bond the CAM to the PDMS forming a peptide 
bond, which strongly binds the molecule to the substrate of out microfluidic 
channel. Therefore, we must simply pour the E-selectin (500 mg) dissolved in 
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1mL of PBS onto the PDMS and leave to react at 37.5 ºC overnight (see Figure 
5.16).  
Manufacturer R&D Systems 
Product 
Recombinant human E-selectin / 
CD62E 
Source 
Chinese Hamster Ovary cell line, 
CHO-derived 
Molecular Mass 58.6 kDa 
Table 5.10: E-selectin chemical characteristics. 
 
 
Figure 5.16: Preparation of E-selectin coated substrate for microfluidic channel. 
5.5 Leukocyte culture 
In order to have a continuous storage of cells for our experiments, we use cell 
cultures. Live leukocytes were acquired and performed continuous medium 
change with the goal of growing the cells and keeping their viability. 
Periodic medium change and cell counting is needed to assess the progress of 
the cells. The following protocol was followed in order to concentrate cells from 
a suspension culture: 
1. Transfer the cell suspension to a sterile centrifuge tube of appropriate 
size and centrifuge for at 3700 rpm for 7 minutes. 
2. Carefully remove the supernatant without disturbing the cell pellet. 
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3. Add the desired volume of fresh medium gently to the side of the tube 
and slowly pipette up and down 2 to 3 times to resuspend the cell pellet. 
4. Transfer the cells to the desired cell container.  
The following protocol was followed as indicated by the Thermo Fisher Scientific 
protocol website (Thermo Fisher Scientific 2016).  
Once we performed the periodic medium change, we counted the cells with the 
use of a haemocytometer following the protocol stated underneath. 
1. Clean the haemocytometer chamber and cover slip with alcohol. Dry and 
fix the coverslip back in position.  
2. Harvest the cells. Add 10 μL of the cells with Trypan Blue to the 
haemocytometer.  Do not overfill.  
3. Place the chamber in the inverted microscope under a 20X objective. 
4. Count the cells in the large, central gridded square (1 mm2).  The gridded 
square is circled in Figure 17.  Multiply by 104 to estimate the number of 
cells per millilitre.  Prepare duplicate samples and average the count.   
 
Figure 5.17: Haemocytometer grid for cell counting (Thermo Fisher Scientific 2016). 
With this method we can observe the size and number of cells being produce, 
to assess the development our cells exhibit. 
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Chapter 6: Experimental Results 
6.1 Sheath Flow Experiment 
This experiment was made in order to evaluate the suitability of our 
hydrodynamic focusing technique, its implications and the relevancy in our final 
experiment. We aimed to measure the width of our focused flow. For this we 
experimented with different flows and ratios to assess the optimal condition for 
our posterior experiment. 
6.1.1 Experimental Setup 
For this experiment, fluorescein and distilled water was used. We introduced 
fluorescein in the central channel and used water as the sheath fluid. These 
were the chosen fluids due to their similar properties and to the fact that 
fluorescein emits luminescence, which represents an advantage because it is 
easy to capture with fluorescence microscopy and the posterior analysing of our 
images are both easy and intuitive. 
 
Figure 6.1: Schematic image illustrating the experimental setup for this assay. 
The microfluidic channel was prepared as described in the previous chapter. 
Then it was connected to syringe pumps (Harvard Apparatus Pump 11 Elite) 
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through 0.5 mm diameter tubes to the inlets of the microfluidic device as shown 
in Figure 6.1. The central channel’s syringe was filled with fluorescein, an 
organic dye used in fluorescence microscopy, and the side syringes were filled 
with distilled water. The syringe pumps were programmed at different flow rates 
as described in Tables 6.1 and 6.2. In Figure 6.2 we can see the final setup. 
 
Figure 6.2: Experimental setup of the hydrodynamic flow focusing essay. 
6.1.2 Results 
In Figure 6.3 the results of the experiments are shown. The images were taken 
with fluorescence microscopy and show the width of the focused flow. In the 
first image to the left (see Figure 6.3(a)) we see that the flow has been reduced 
to 36.3 μm in width due to a 1:2 side inlet flow ratio (see Table 6.1). 
Consequently, in the next figures (see Figure 6.3(b)-(c)) the flow ratio was 
altered to a 1:6 ratio and a 1:10 ratio. Table 6.1 show the results depicted in 
Figure 6.3.  
 
Figure 6.3: Hydrodynamic flow focusing visualization on microfluidic channel. Fluorescence microscopy 
20x objective. 
36.3 μm 10.89 μm 5.44 μm  
(b) (c) (a) 
63 
 
 Image 1 Image 2 Image 3 
Sheath Flow 
Ratio 
1:2 1:6 1:10 
H2O Flow Rate 20 μL/h 60 μL/h 100 μL/h 
Fluorescein Flow 
Rate 
10 μL/h 10 μL/h 10 μL/h 
Total Flow Rate 50 μL/h 130 μL/h 210 μL/h 
Table 6.1: Sheath flow ratios used in hydrodynamic flow focusing experiment. See also Figure 6.3  
Constant Sample Flow 
Fluorine Rate (μL/h) Sheath Rate (μL/h) Pixels Size (μm) 
10 20 100 36,3 
10 40 50 18,15 
10 60 30 10,89 
10 80 20 7,26 
10 100 15 5,445 
Constant Sheath Flow 
20 100 29 10,527 
30 100 33 11,979 
40 100 40 14,52 
50 100 41 14,883 
Table 6.2: Hydrodynamic focused flow under different sample flows and sheath flows. First the central 
channel remained constant while the side channel's flow rate was increased. On the second iteration of the 
experiment, the sheath channels remained constant while the central channel’s flow was increased in 
increments of 10 μL/h. 
In order to measure the width of the hydrodynamic flow the following formula 
was used: 
 𝑛º 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 × 
3.63 × 𝑏𝑖𝑛𝑛𝑖𝑛𝑔
𝑙𝑒𝑛𝑠 𝑚𝑎𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛
= 𝜇𝑚 , (5.1) 
where binning represents the number of cluster of pixels into a single pixel. In 
these images this number is equal to 2. Lens magnification, on the other hand, 
is the magnification used in the lens in the fluorescence microscopy. To take 
these images we used a 20x magnification. 
 𝑛º 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 ×
3.63 × 2 
20
= 𝜇𝑚 . (5.2) 
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6.1.3 Discussion 
As we’ve seen previously, the setup and execution of this experiment show a 
promising hydrodynamic focusing. We have demonstrated that by varying the 
flow rates in each of the inputs we can modify the width of out focused channel. 
This is a fundamental first step in the development of our device, considering 
that we can now control the amount of fluid and cells that will pass through the 
central portion of our channel. 
We must take a minute to point out the possible errors in calculating the size of 
the sheath. The error in the calculations may be of ±1 μm; this is not significant 
as the size of the leukocyte is generally 10 μm.  
When using the final iteration of our design, the user may want to change the 
conditions of flow in the channel therefore we can make many combinations of 
flow rates to fit our needs. In our case the since we want a single cell focused 
flow, we aim to have dimensions ranging from 11 μm to 15 μm therefore we 
could use the above tested combinations. When choosing said flow rates, we 
must elect appropriate rates bearing in mind the total flow downstream from 
focusing point. Once the three flows meet in the channel the total flow rate 
would be the sum of the three flow rates, as indicated in the following equation: 
 𝑄 = 𝑄𝑐𝑒𝑛𝑡𝑟𝑎𝑙 𝑐ℎ𝑎𝑛𝑛𝑒𝑙 + 2 × 𝑄𝑠𝑖𝑑𝑒 𝑐ℎ𝑎𝑛𝑛𝑒𝑙𝑠 . 
(5.3) 
As we know, cells will behave differently with different flows; therefore, we must 
adjust these parameters accordingly. 
6.2 Rolling Cell Experiment 
In this second experiment, we recreate the rolling cell experiment on a simple 
straight channel microfluidic device. The goal of this experiment is to test the 
rolling conditions in which the last experiment will take place. 
We shall experiment under the same conditions as in the last experiment and 
expose the problems we face when working with the absence of a 
hydrodynamic focusing module. 
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6.2.1 Experimental Setup 
 
Figure 6.4: Schematic image showing the experimental setup for this assay. 
The setup is very similar to the previous experiment, changing in aspects such 
as the number of pumps used and the nature of the fluid used. Due to the fact 
that we are testing live leukocytes on this assay, we used PBS as working fluid 
in order to keep the medium as stable as possible. 
As explained in chapter 6.4, this experiment needs an E-selectin coated surface 
for the leukocytes to bind correctly; therefore a previously treated substrate was 
used for this experiment. The conditions, as explained previously, do not 
change much from the previous experiment; however we used Calcein AM for 
this experiment to stain the cytoplasm of the cell. 
Calcein AM is a fluorescent dye with emission wavelengths of 495/515 nm. This 
dye is used in biology due to its ability to penetrate the cellular membrane in live 
cells, making it a very useful tool for testing cell viability and for short term cell 
labelling. 
6.2.2 Results 
The following results were obtained at 0.2 Pa of wall shear stress and are 
depicted in Figure 6.5 and Figure 6.6. As we can observe only leukocytes on 
the side of the channels attach, where the fluid flow is slower, leaving the 
central section completely barren. 
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Figure 6.5: Top view of microfluidic channel. Leukocytes flow on the edges of the channel as opposed to 
the central area where we would expect them. 
 
Figure 6.6: Top view of microfluidic channel. Leukocytes flow path is scattered throughout the whole 
domain of the channel. 
6.2.3 Discussion 
As we can see in the Figures 6.5 and 6.6, the conditions in which the 
measurements take place aren’t the ideal position for us to have an accurate 
reading on the results of the experiment. This is the reason we need a sheath 
flow, in order to focus the lymphocytes in the central domain to control all the 
variables in our future tests. 
Besides this inconvenience, the setup works as expected: the leukocytes bind 
to the substrate and roll at the appropriate speeds. 
flow 
50 μm 
flow 
50 μm 
67 
 
6.3 Rolling Cell Sheath Flow Experiment 
In this experiment we test the definitive version of our experiment in order to 
validate the prototype we have created. We shall introduce a syringe of PBS 
with live lymphocytes suspended and produce a sheath flow to centre the 
immune cells in the channel to have more controllable interface. 
6.3.1 Experimental Setup 
The experimental setup is similar to those explained in the above experiments. 
The substrate was prepared the day before and left overnight in the incubator at 
37.5 ºC, as explained in chapter 5. 
The channel used was prepared on the day of the experiment following the 
procedure of soft lithography explained in chapter 5. Once the channel was 
prepared it was sterilized accordingly with ethanol and distilled water following 
the same protocol as the experiments explained previously. 
The syringes used for the experiments contained PBS alone and PBS with 
lymphocytes suspended in them, respectively, prepared following the same 
steps as the previous experiments. The lymphocytes dyed with Calcein AM, in 
the same way we performed in the previous experiment. 
6.3.2 Results 
The results observed in this experiment were as expected. When the 
lymphocytes were introduced into the microfluidic channel, the cells were 
focused into the central section of the posterior channel. This is due to the 
action of the hydrodynamic focusing module we have built. 
As we can see in the previous experiment and on Figure 6.5, we can observe 
that the flow of the leukocytes is random, the same happens in Figure 6.7(a) 
and Figure 6.7(b). However once the cells have been focused by the action of 
the sheath flow they circulate through the centre of the channel as observed in 
the following images of Figure 6.7(c)-(h). 
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Figure 6.7: Time-lapse visualizing the flow of the lymphocytes through the flow focusing module. The total 
time of this video lasts 1 second. The leukocyte can be observed as a white dot over a grey background. 
This image was extracted using fluorescence microscopy. 
We have to bear in mind, that although we are focusing the flow of the 
lymphocytes in the centre of the channel, due to the physics of the 
hydrodynamic focusing section, the speed at which these cells move along the 
channel will also increase. In this said section, we are pumping three times the 
volume of fluid as pumped in the initial section therefore as we explained in 
chapter 3, the increase of volume being pumped under the constant width of the 
channel will cause the speed of the particles to be increased.  
6.3.3 Discussion 
The initial results were positive, and we managed to obtain the results we were 
looking for. The ultimate goal was to create a stream of focused cells in order to 
analyse them in a more controlled environment. However good the result may 
be, there are certain aspects we must talk about regarding this experiment. 
Firstly, as we have observed in the results, the speed of the cells increases by a 
certain factor depending on the flow in the inlets. The speed of the particle will 
see itself increased depending on how focused the flow of cells are. Meaning 
that the more focused we desire our model to be the higher the speed will be in 
our channel, due to the flow of higher volumes per unit of time pumped into the 
(a) (b) (c) 
(d) (e) (f) 
(g) (h) 
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system. This may pose certain problems, due to the limitations of the equipment 
used for the experiment. 
If we desire a certain low particle speed (where Q ≤ 20 μL/h) where we aim to 
perform an experiment with a specific pressure factor and we want a high 
focusing rate, the central inlets must pump the experimental fluid at very low 
flows, meaning that the microfluidic pumps used might have certain limitations. 
When performing high focusing rates and lower particle speed experiments, the 
microfluidic pumps exhibited technical limitations and generated a pulsation 
effect in the fluid. This pulsation is a very negative effect that we want to 
eradicate at all costs. 
Secondly, we observed that the binding with the E-selectin substrate was not 
always achieved and suspect this is due to the absence of contact with the 
substrate of the channel. Due to this most of the cells will flow along the channel 
never attaching to the substrate. However nothing can be done, because in the 
event of forcing the cells to attach we must exert a force onto the lymphocyte 
that would modify the behaviour of the cell significantly. 
All in all, one thing is clear, although the experiment has given us positive 
results, luck is also a factor when performing experiments because lymphocytes 
can fail to attach as discussed previously. 
6.4 Pulsation Experiment 
In this experiment we aim to observe at what flow the microfluidic pump, 
Harvard Apparatus Pump 11 Elite, exhibits mechanical limitation and thus affect 
the flow of our fluid causing pulsation. 
6.4.1 Experimental Setup 
For this experiment we fabricated a simple straight channel microfluidic chip 
and pumped into the channel micro particles suspended in a distilled water 
solution at flows under 5 μL/h as seen in Figure 6.8. We then observed the flow 
of the fluid under the fluorescence microscope and analysed the results. 
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Figure 6.8: Schematic image showing experimental setup for this section. 
6.4.2 Results 
After testing a range of different flows, we observed pulsation in flows under 5 
μL/h. 
6.4.3 Discussion 
As pointed out in the results section, pulsation occurs in flows under 5 μL/h, 
indicating a limitation in the apparatus used in our experimentation. Therefore, 
when performing experiments that require low flow rates, we must be very 
careful not to surpass this value because it could introduce undesired 
alterations to our experiment that could change the results of our tests. 
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Chapter 7: Conclusion 
7.1 Conclusions 
After analysing all the relevant results from the different experiments we can 
conclude the following: 
 The potentiality of microfluidics for biomedical research has been proved. 
Microfluidics poses as an excellent technology that is widely used in 
many labs around the world. 
 The importance of multiphysics simulation software in microfluidic 
research has been confirmed. 
 A microfluidic system for leukocyte experimentation or Lab on a Chip that 
overcomes the initial non central rolling problem has been successfully 
developed. 
 Although the system solves many problems, in cases of low flow rates, 
the system presents limitations due to the equipment used.   
7.2 Future Work 
Although the system that has been designed is fully functional and could be 
used in future research, there is still room for improvement. The following 
advances are proposed as a way for improving the capabilities of the system. 
 Continue performing tests to evaluate functionality. 
 Perform rolling cell adhesion analysis via Nomura´s software to compare 
the numerical data. 
 Experiment with different leukocytes and cells. 
 Experiment with circulating cancer cells. 
 Develop a new substrate with live epithelial human cells for future 
experiments. 
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